Biotech

All Articles

GSK's long-acting breathing problem drug halved strikes in stage 3

.GSK's long-acting bronchial asthma therapy has actually been revealed to halve the number of assaul...

AstraZeneca, Daiichi unpack Dato-DXd's total survival fall short

.AstraZeneca as well as Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) has actually s...

Roivant reveals new 'vant' to evolve Bayer high blood pressure med

.Matt Gline is actually back with a brand new 'vant' firm, after the Roivant Sciences CEO paid for B...

Viridian eye condition stage 3 smash hits, evolving press to rival Amgen

.Viridian Therapies' stage 3 thyroid eye health condition (TED) clinical trial has hit its key and s...

Bain reveals $3B fund forever scientific research providers

.With a tough performance history for determining rough diamonds, Bain Funding Lifespan Sciences (BC...

Genentech's cancer cells restructure created 'for clinical reasons'

.The latest choice to combine Genentech's 2 cancer departments was actually created "medical reasons...

Tern oral GLP-1 shows 5% weight management at 1 month at highest dose

.Terns Pharmaceuticals' choice to fall its liver condition ambitions might yet repay, after the biot...

Merck, Daiichi replay early success in little mobile bronchi cancer with improved ADC records

.Merck &amp Co.'s long-running attempt to land a strike on little cell lung cancer (SCLC) has actual...

Boehringer, Bayer innovation bronchi cancer cells medications toward Astra fight

.Some patients with non-small tissue bronchi cancer cells (NSCLC) have mutations in a genetics calle...

MBX aims for $136M IPO to take rival to Ascendis into stage 3

.MBX has fleshed out programs to absorb over $136 million coming from its IPO as the biotech wants t...